John Anil Lincoln MD. PHD

Each company has faced its own set of issues, with Sarepta being one of many that are trying to make amends for some issues that have happened in the past. Although there happened to be some issues with the data that was coming from Sarepta, their approval of the drug that can assist with muscular...

What is multiple sclerosis (MS)?Multiple sclerosis (MS) is a complex disease, which affects the central nervous system, which is made up of the brain and spinal cord along with optic nerves. Multiple sclerosis is not a terminal illness but a lifelong medical condition. Moreover, MS is neither...

Research shows that patients newly diagnosed with Alzheimer's disease who recently began using antidepressents are at a higher risk for head injuries and traumatic brain injuries. Heidi Taipale and colleagues from the University of Eastern Finland wrote that for older people who use...

Drugs used to treat type 2 diabetes, belonging to a class called glitazones (GTZs) may reduce the risk of Parkinson’s by as much as 28 percent, a study suggests. It was a large scale study done by analyzing more than 100 million prescriptions. ...

Researchers are continuously uncovering new ways to help cure multiple sclerosis (MS). One area in particular that shows promising results is neuroprotection. Neuroprotection aims to prevent nerve cells from becoming damaged, thus slowing down the progression of the disease. Initially, MS symptoms...

Multiple sclerosis can be difficult to diagnose, as many of the symptoms do not even appear until later in one's life. However, a recent study has shown that the risk level in children is able to be diagnosed early with MRI brain scans.DiagnosisSometimes MRI brain scans can show MS before any...